科兴制药: 第二届监事会第二十五次会议决议公告

Group 1 - The company held its 25th meeting of the second Supervisory Board on August 22, 2025, which was conducted in accordance with relevant laws and regulations [1] - The Supervisory Board approved the 2025 semi-annual report and its summary, affirming that the report accurately reflects the company's financial status and operational results for the first half of 2025 [1][2] - The voting results for the approval of the semi-annual report were 3 votes in favor, with no votes against or abstentions [2] Group 2 - The Supervisory Board also approved a special report on the storage and actual use of raised funds for the first half of 2025, confirming compliance with relevant regulations and proper management of the funds [2] - The company ensured that the raised funds were stored in dedicated accounts and used for specified purposes, with timely disclosure of related information [2] - The voting results for the approval of the special report on raised funds were also 3 votes in favor, with no votes against or abstentions [2]